Intangible Assets and Goodwill (Tables)

3 Months Ended

Apr. 01, 2018

Goodwill and Intangible Assets Disclosure [Abstract]



(Dollars in Millions)	April 1, 2018		December 31, 2017
Intangible assets with definite lives:
Patents and trademarks — gross	$	35,980	36,427
Less accumulated amortization	7,594		7,223
Patents and trademarks — net ⁽¹⁾	28,386		29,204
Customer relationships and other intangibles — gross	21,141		20,204
Less accumulated amortization	7,748		7,463
Customer relationships and other intangibles — net	13,393		12,741
Intangible assets with indefinite lives:
Trademarks	7,113		7,082
Purchased in-process research and development	3,473		4,201
Total intangible assets with indefinite lives	10,586		11,283
Total intangible assets — net	$	52,365	53,228

⁽¹⁾ Net of approximately $0.6 billion classified as assets held for sale on the Consolidated Balance Sheet. $0.5 billion is related to the divestiture of Valchlor and $0.1 billion is related to the divestiture of the LifeScan business, both of which were pending as of April 1, 2018.

Goodwill

Goodwill as of April 1, 2018 was allocated by segment of business as follows:



(Dollars in Millions)	Consumer		Pharm	Med Devices			Total
Goodwill, net at December 31, 2017	$	8,875	9,109	13,922			31,906
Goodwill, related to acquisitions	—		—	53			53
Goodwill, related to divestitures	—		—	—			—
Currency translation/Other	24		147	(981	)	(1)	(810	)
Goodwill, net at April 1, 2018	$	8,899	9,256	12,994			31,149

⁽¹⁾Net of approximately $1.0 billion classified as assets held for sale on the Consolidated Balance Sheet, related to the divestiture of the LifeScan business which was pending as of April 1, 2018.